Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2005 2
2006 1
2007 5
2008 3
2009 2
2010 5
2011 3
2012 6
2013 5
2014 3
2015 3
2016 6
2017 2
2018 2
2019 2
2020 1
2021 2
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's Adverse Event Reporting System.
Pera V, van Vaerenbergh F, Kors JA, van Mulligen EM, Parry R, de Wilde M, Lahousse L, van der Lei J, Rijnbeek PR, Verhamme KMC. Pera V, et al. Among authors: van mulligen em. Pharmacoepidemiol Drug Saf. 2024 Jan;33(1):e5743. doi: 10.1002/pds.5743. Epub 2023 Dec 29. Pharmacoepidemiol Drug Saf. 2024. PMID: 38158381
Parasitic infections related to anti-type 2 immunity monoclonal antibodies: a disproportionality analysis in the food and drug administration's adverse event reporting system (FAERS).
Pera V, Brusselle GG, Riemann S, Kors JA, Van Mulligen EM, Parry R, de Wilde M, Rijnbeek PR, Verhamme KMC. Pera V, et al. Among authors: van mulligen em. Front Pharmacol. 2023 Nov 14;14:1276340. doi: 10.3389/fphar.2023.1276340. eCollection 2023. Front Pharmacol. 2023. PMID: 38035014 Free PMC article.
eTRANSAFE: data science to empower translational safety assessment.
Sanz F, Pognan F, Steger-Hartmann T, Díaz C, Asakura S, Amberg A, Bécourt-Lhote N, Blomberg N, Bosc N, Briggs K, Bringezu F, Brulle-Wohlhueter C, Brunak S, Bueters R, Callegaro G, Capella-Gutierrez S, Centeno E, Corvi J, Cronin MTD, Drew P, Duchateau-Nguyen G, Ecker GF, Escher S, Felix E, Ferreiro M, Frericks M, Furlong LI, Geiger R, George C, Grandits M, Ivanov-Draganov D, Kilgour-Christie J, Kiziloren T, Kors JA, Koyama N, Kreuchwig A, Leach AR, Mayer MA, Monecke P, Muster W, Nakazawa CM, Nicholson G, Parry R, Pastor M, Piñero J, Oberhauser N, Ramírez-Anguita JM, Rodrigo A, Smajic A, Schaefer M, Schieferdecker S, Soininen I, Terricabras E, Trairatphisan P, Turner SC, Valencia A, van de Water B, van der Lei JL, van Mulligen EM, Vock E, Wilkinson D. Sanz F, et al. Among authors: van mulligen em. Nat Rev Drug Discov. 2023 Aug;22(8):605-606. doi: 10.1038/d41573-023-00099-5. Nat Rev Drug Discov. 2023. PMID: 37316648 No abstract available.
Use of unstructured text in prognostic clinical prediction models: a systematic review.
Seinen TM, Fridgeirsson EA, Ioannou S, Jeannetot D, John LH, Kors JA, Markus AF, Pera V, Rekkas A, Williams RD, Yang C, van Mulligen EM, Rijnbeek PR. Seinen TM, et al. Among authors: van mulligen em. J Am Med Inform Assoc. 2022 Jun 14;29(7):1292-1302. doi: 10.1093/jamia/ocac058. J Am Med Inform Assoc. 2022. PMID: 35475536 Free PMC article.
The eTRANSAFE Project on Translational Safety Assessment through Integrative Knowledge Management: Achievements and Perspectives.
Pognan F, Steger-Hartmann T, Díaz C, Blomberg N, Bringezu F, Briggs K, Callegaro G, Capella-Gutierrez S, Centeno E, Corvi J, Drew P, Drewe WC, Fernández JM, Furlong LI, Guney E, Kors JA, Mayer MA, Pastor M, Piñero J, Ramírez-Anguita JM, Ronzano F, Rowell P, Saüch-Pitarch J, Valencia A, van de Water B, van der Lei J, van Mulligen E, Sanz F. Pognan F, et al. Among authors: van mulligen e. Pharmaceuticals (Basel). 2021 Mar 8;14(3):237. doi: 10.3390/ph14030237. Pharmaceuticals (Basel). 2021. PMID: 33800393 Free PMC article.
Guidelines for FAIR sharing of preclinical safety and off-target pharmacology data.
Briggs K, Bosc N, Camara T, Diaz C, Drew P, Drewe WC, Kors J, Van Mulligen E, Pastor M, Pognan F, Quintana JR, Sarntivijai S, Steger-Hartmann T. Briggs K, et al. Among authors: van mulligen e. ALTEX. 2021;38(2):187-197. doi: 10.14573/altex.2011181. Epub 2021 Feb 25. ALTEX. 2021. PMID: 33637997 Free article.
58 results